GNRH1 and polycystic ovary syndrome: These results indicate that EA effectively restores the expression of Itgb1 and reactivates the FAK/TGF-βR1/Smad2 signaling pathway, alleviating morphological and functional abnormalities of the GnRH–tanycyte unit in PCOS-like mice.